General Information
Version
1.1
Revision date
2025-01-12
Product name
Sodium bromate TECHNICAL
CAS No.
7789-38-0
REACH No
01-2120767488-36-XXXX
1.2.2. Uses advised against
The product, as such or as a component of a mixture, is not intended to be used by consumers (as defined by the REACH Regulation)
Emergency telephone
+44 (0) 1270 502894
Icons in SDS
Company Information
company name
VWR International Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
SDS@avantorsciences.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H272, H302, H315, H319, H335
Hazard statements
Code
Statements
H272
May intensify fire; oxidiser
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture
Signal word
Danger
Hazard statements
H272 May intensify fire; oxidiser. H302 Harmful if swallowed. H315 Causes skin irritation. H319 Causes serious eye irritation. H335 May cause respiratory irritation.
Precautionary statements
P210 Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P221 Take any precaution to avoid mixing with combustibles. P280 Wear protective gloves/protective clothing/eye protection/face protection. P261 Avoid breathing dust/fume/gas/mist/vapours/spray. P264 Wash hands thoroughly after handling. P337+P313 If eye irritation persists: Get medical advice/attention. P403+P233 Store in a well-ventilated place. Keep container tightly closed.
2.3 Other hazards
This substance does not meet the PBT/vPvB criteria of REACH, Annex XIII. This product does not contain a substance that has endocrine disrupting properties.
2.1 Classification of the substance or mixture
2.1.1 Classification according to Regulation (EC) No 1272/2008 [CLP] Hazard classes and hazard categories Hazard statements Oxidising solid, category 2 H272 Acute toxicity, category 4, oral H302 Skin irritation, category 2 H315 Eye irritation, category 2 H319 Specific target organ toxicity (single exposure), category 3, Respiratory tract irritation H335
